🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

7+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 7 of 7 recruiting trials for “mantle-cell-lymphoma”

Phase 2RecruitingNCT07168317 ↗

Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITL

👨‍⚕️ Wei Sang Doctor📍 1 site📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT06522737 ↗

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

🏥 SecuraBio📍 43 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT07058103 ↗

Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL

🏥 The Affiliated Hospital of Xuzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06756308 ↗

A Study of Enasidenib in People With T-Cell Lymphoma

👨‍⚕️ Zachary Epstein-Peterson, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06550141 ↗

Emapalumab Prevention of CAR-T Cell Associated Toxicities

👨‍⚕️ Matthew Frigault, MD, Massachusetts General Hospital📍 2 sites📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06393738 ↗

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

🏥 Arvinas Inc.📍 17 sites📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT05544019 ↗

Study of SGR-1505 in Mature B-Cell Neoplasms

👨‍⚕️ Frank G Basile, M.D., Schrodinger Inc.📍 36 sites📅 Started Apr 2023View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →